eXoZymes, Inc.

EXOZ

NASDAQHealthcareBiotechnology

Open in GoAI

Latest quote

$7.68

+$0.11 · +1.56%

Aug 21, 3:55 PM ET

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

24/100

GoAI score

Sell

Trim exposure — unfavorable risk-reward

Valuation

Expensive

Momentum

Strong Down

Sentiment

Mixed

Risk resilience

Extreme Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

eXoZymes, Inc. operates as a development stage biotechnology company. It focuses on the development of enzyme modules and cell-free exozyme biosolutions for synthetic biology manufacturing. The company was formerly known as Invizyne Technologies, Inc. and changed its name to eXoZymes, Inc. in February 2025. eXoZymes, Inc. was incorporated in 2014 and is headquartered in Monrovia, California.

Industry: Biotechnology
Sector: Healthcare
Headquarters: US
CEO: Michael Heltzen
Listed since: Nov 13, 2024
Employees: 32